Nucleic Acids Research, 1989, Vol. 17, No. 20 8073-8091
© 1989
MOLECULAR BIOLOGY |
Repair synthesis by human cell extracts in DNA damaged by cis- and trans-diamminedichloroplatinum(II)
Imperial Cancer Research Fund, Clare Hall Laboratories South Mimms, Herts EN6 3LD, UK
Received July 28, 1989. Revised September 20, 1989. Accepted September 20, 1989.
DNA damage was induced in closed circular plasmid DNA by treatment with cis- or trans-diamrninedichloroplatinurn(II)- These plasmids were used as substrates in reactions to give quantitative measurements of DNA repair synthesis mediated by cell free extracts from human lymphoid cell lines. Adducts induced by both drugs stimulated repair synthesis in a dose dependent manner by an ATP-requiring process. Measurements by an isopycnic gradient sedimentation method gave an upper limit for the average patch sizes in this in vitro system of around 140 nucleotides. It was estimated that up to 3% of the drug adducts induce the synthesis of a repair patch. The repair synthesis is due to repair of a small fraction of frequent drug adducts, rather than extensive repair of a rare subclass of lesions. Nonspecific DNA synthesis in undamaged plasmids, caused by exonucleolytic degradation and resynthesis, was reduced by repeated purification of intact circular forms. An extract made from cells belonging to xeroderma pigmentosum complementation group A was deficient in repair synthesis in response to the presence of cis- or trans-diamminedichloroplatinum(n) adducts in DNA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. R. Albertella, C. M. Green, A. R. Lehmann, and M. J. O'Connor A Role for Polymerase {eta} in the Cellular Tolerance to Cisplatin-Induced Damage Cancer Res., November 1, 2005; 65(21): 9799 - 9806. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. U. De Silva, P. J. McHugh, P. H. Clingen, and J. A. Hartley Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin Nucleic Acids Res., September 1, 2002; 30(17): 3848 - 3856. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jiang and L.-Y. Yang Cell Cycle Checkpoint Abrogator UCN-01 Inhibits DNA Repair: Association with Attenuation of the Interaction of XPA and ERCC1 Nucleotide Excision Repair Proteins Cancer Res., September 1, 1999; 59(18): 4529 - 4534. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Krueger, L. H.F. Mullenders, and A. Hartwig Nickel(II) increases the sensitivity of V79 Chinese hamster cells towards cisplatin and transplatin by interference with distinct steps of DNA repair Carcinogenesis, July 1, 1999; 20(7): 1177 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Coin, P. Frit, B. Viollet, B. Salles, and J.-M. Egly TATA Binding Protein Discriminates between Different Lesions on DNA, Resulting in a Transcription Decrease Mol. Cell. Biol., July 1, 1998; 18(7): 3907 - 3914. [Abstract] [Full Text] |
||||
![]() |
B. Lambert, J.-L. Jestin, P. Bréhin, C. Oleykowski, A. T. Yeung, P. Mailliet, C. Prétot, J.-B. L. Pecq, A. Jacquemin-Sablon, and J.-C. Chottard Binding of the Escherichia coli UvrAB Proteins to the DNA Mono- and Diadducts of cis-[N-2-Amino-N-2-methylamino-2,2,1-bicycloheptane]dichloroplatinum(II) and Cisplatin J. Biol. Chem., September 8, 1995; 270(36): 21251 - 21257. [Abstract] [Full Text] [PDF] |
||||




